Evolent Health, Inc. (EVH)Healthcare | Health Information Services | Arlington, United States | NYSE
5.92 USD
|
Hot Take ↕ | July 11, 2026, 3:01 a.m. EDT
The investment case here is fundamentally broken. While the stock trades at a depressed multiple relative to book value, the business is generating significant losses with negative operating margins and a crushing return on equity. The multi-year price trajectory confirms this deterioration, showing three consecutive years of decline and a nearly 40% drop over the last nine years. This is not a value opportunity; it is a value trap where the market has correctly priced in the inability to generate sustainable earnings. The lack of a dividend and the heavy speculative positioning in put options reinforce the view that capital is fleeing this name. The recent price surge appears to be a technical bounce off lows rather than a reversal of the secular downtrend. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.128551 |
| AutoETS | 0.177336 |
| AutoARIMA | 0.194135 |
| MSTL | 0.194765 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 29% |
| H-stat | 27.71 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.207 |
| Excess Kurtosis | -1.08 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 248.598 |
| Revenue per Share | 16.663 |
| Market Cap | 665,887,936 |
| Forward P/E | 15.38 |
| Beta | 0.77 |
| Profit Margins | -26.29% |
| Website | https://www.evolent.com |
As of July 11, 2026, 3:01 a.m. EDT: Speculators are heavily positioned for downside protection, evidenced by massive open interest in out-of-the-money puts (strikes $2.50 and $5.00) across nearly all expirations, while call activity remains sparse and concentrated in deep out-of-the-money strikes ($15.00). This distribution suggests a market consensus expecting further weakness rather than a rally, despite the recent price bounce.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.47933155 |
| Address1 | 1,812 N. Moore Street |
| Address2 | Suite 1705 |
| All Time High | 39.779 |
| All Time Low | 2.095 |
| Ask | 5.92 |
| Ask Size | 900 |
| Audit Risk | 3 |
| Average Analyst Rating | 1.7 - Buy |
| Average Daily Volume10 Day | 2,256,410 |
| Average Daily Volume3 Month | 2,574,642 |
| Average Volume | 2,574,642 |
| Average Volume10Days | 2,256,410 |
| Beta | 0.765 |
| Bid | 5.9 |
| Bid Size | 500 |
| Board Risk | 2 |
| Book Value | 3.524 |
| City | Arlington |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 6 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 5.92 |
| Current Ratio | 1.317 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 5.94 |
| Day Low | 5.68 |
| Debt To Equity | 248.598 |
| Display Name | Evolent Health |
| Earnings Call Timestamp End | 1,786,046,400 |
| Earnings Call Timestamp Start | 1,786,046,400 |
| Earnings Timestamp | 1,786,019,400 |
| Earnings Timestamp End | 1,786,019,400 |
| Earnings Timestamp Start | 1,786,019,400 |
| Ebitda | 74,355,000 |
| Ebitda Margins | 0.03937 |
| Enterprise To Ebitda | 20.298 |
| Enterprise To Revenue | 0.799 |
| Enterprise Value | 1,509,284,864 |
| Eps Current Year | 0.19654 |
| Eps Forward | 0.3849 |
| Eps Trailing Twelve Months | -4.68 |
| Esg Populated | 0 |
| Exchange | NYQ |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 4.5374 |
| Fifty Day Average Change | 1.3826003 |
| Fifty Day Average Change Percent | 0.30471203 |
| Fifty Two Week Change Percent | -47.933155 |
| Fifty Two Week High | 11.81 |
| Fifty Two Week High Change | -5.8900003 |
| Fifty Two Week High Change Percent | -0.4987299 |
| Fifty Two Week Low | 2.095 |
| Fifty Two Week Low Change | 3.825 |
| Fifty Two Week Low Change Percent | 1.8257756 |
| Fifty Two Week Range | 2.095 - 11.81 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,433,511,000,000 |
| Float Shares | 93,569,625 |
| Forward Eps | 0.3849 |
| Forward P E | 15.380618 |
| Free Cashflow | 52,930,624 |
| Full Exchange Name | NYSE |
| Full Time Employees | 4,200 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.20181 |
| Gross Profits | 381,185,984 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.03176 |
| Held Percent Institutions | 1.0087 |
| Implied Shares Outstanding | 112,481,067 |
| Industry | Health Information Services |
| Industry Disp | Health Information Services |
| Industry Key | health-information-services |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia. |
| Long Name | Evolent Health, Inc. |
| Market | us_market |
| Market Cap | 665,887,936 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_225523981 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -533,783,008 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 665,887,916 |
| Number Of Analyst Opinions | 13 |
| Open | 5.76 |
| Operating Cashflow | 33,294,000 |
| Operating Margins | -0.02043 |
| Overall Risk | 2 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.93 |
| Phone | 571 389 6000 |
| Previous Close | 5.92 |
| Price Eps Current Year | 30.121096 |
| Price Hint | 2 |
| Price To Book | 1.6799092 |
| Price To Sales Trailing12 Months | 0.35254064 |
| Profit Margins | -0.26287 |
| Quick Ratio | 1.197 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.66667 |
| Region | US |
| Regular Market Change | 0.0 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 5.94 |
| Regular Market Day Low | 5.68 |
| Regular Market Day Range | 5.68 - 5.94 |
| Regular Market Open | 5.76 |
| Regular Market Previous Close | 5.92 |
| Regular Market Price | 5.92 |
| Regular Market Time | 1,784,039,560 |
| Regular Market Volume | 184,088 |
| Return On Assets | -0.00449 |
| Return On Equity | -0.65112 |
| Revenue Growth | 0.026 |
| Revenue Per Share | 16.663 |
| Sand P52 Week Change | 0.20365608 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 1 |
| Shares Outstanding | 112,481,067 |
| Shares Percent Shares Out | 0.1407 |
| Shares Short | 15,830,692 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 14,794,987 |
| Short Name | Evolent Health, Inc |
| Short Percent Of Float | 0.1424 |
| Short Ratio | 6.03 |
| Source Interval | 15 |
| State | VA |
| Symbol | EVH |
| Target High Price | 8.0 |
| Target Low Price | 3.0 |
| Target Mean Price | 5.88462 |
| Target Median Price | 6.0 |
| Total Cash | 142,028,000 |
| Total Cash Per Share | 1.263 |
| Total Debt | 985,425,024 |
| Total Revenue | 1,888,825,984 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -4.68 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 4.38705 |
| Two Hundred Day Average Change | 1.5329499 |
| Two Hundred Day Average Change Percent | 0.34942612 |
| Type Disp | Equity |
| Volume | 184,088 |
| Website | https://www.evolent.com |
| Zip | 22,209 |